Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

CMTM Proteins in Macrophage: Membrane Trafficking, Immune Checkpoints, and Emerging Roles Across Disease.

Created on 10 Nov 2026

Authors

XiaoXin Wang, Min Ling, FuJun Liu

Published in

Journal of inflammation research. Volume 19. Pages 614531. Epub Nov 05, 2026.

Abstract

The CKLF-like MARVEL transmembrane domain-containing (CMTM) family has emerged as a functionally diverse group of membrane-associated regulators involved in receptor stability, vesicular trafficking, and immune homeostasis. Increasing evidence suggests that selected CMTM proteins influence macrophage biology in a context-dependent manner, particularly under conditions of tumor-associated immune suppression, systemic inflammatory stress, and innate immune overactivation. Among the family members implicated to date, CMTM6 is the best-established regulator of programmed death-ligand 1 (PD-L1) stability and thereby contributes to immune evasion in cancer, with emerging evidence suggesting additional effects on macrophage immunoregulatory programming in selected tumor settings. CMTM4 shares partially overlapping activity in PD-L1 regulation, but its macrophage-specific role, especially in sepsis-associated immune dysfunction, remains incompletely defined. In contrast, CMTM7 has been identified as a candidate endogenous negative regulator of macrophage inflammatory activation, functioning through trafficking-dependent control of Toll-like receptor 4 (TLR4) signaling and signal termination. Collectively, current data support a model in which CMTM proteins modulate macrophage responses through membrane-proximal mechanisms governing checkpoint expression, receptor trafficking, inflammatory amplitude, and possibly cell survival. In this review, we summarize current evidence connecting CMTM proteins to macrophage inflammation response in cancer, sepsis, and other inflammatory disease, distinguish established mechanisms from emerging hypotheses, discuss major methodological limitations, and outline priorities for future mechanistic and translational studies.

PMID:
43005918
Bibliographic data and abstract were imported from PubMed on 10 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 9
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement